technetium has been researched along with Pulmonary Sarcoidosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruno, P; Galli, F; Lanzolla, T; Malviya, G; Mariotta, S; Pietrangeli, V; Ragni, P; Ricci, A; Scopinaro, F; Signore, A | 1 |
Grutters, JC; Keijsers, RG; Malviya, G; Meek, B; Signore, A; van de Garde, EM; Vis, R | 1 |
1 trial(s) available for technetium and Pulmonary Sarcoidosis
Article | Year |
---|---|
In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis.
Topics: Adult; Female; Humans; Infliximab; Lung; Male; Middle Aged; Positron-Emission Tomography; Radiography; Sarcoidosis, Pulmonary; Technetium; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 2015 |
1 other study(ies) available for technetium and Pulmonary Sarcoidosis
Article | Year |
---|---|
⁹⁹mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Middle Aged; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Interleukin-2; Sarcoidosis, Pulmonary; Single Photon Emission Computed Tomography Computed Tomography; Technetium; Tumor Necrosis Factor-alpha | 2016 |